Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prenatal diagnosis of 30 fetuses at risk for fragile X syndrome.
Grasso M, Perroni L, Colella S, Piombo G, Argusti A, Lituania M, Buscaglia M, Giussani U, Grimoldi MG, Bricarelli FD. Grasso M, et al. Among authors: argusti a. Am J Med Genet. 1996 Jul 12;64(1):187-90. doi: 10.1002/(SICI)1096-8628(19960712)64:1<187::AID-AJMG33>3.0.CO;2-H. Am J Med Genet. 1996. PMID: 8826473
Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients.
Grasso M, Faravelli F, Lo Nigro C, Chiurazzi P, Sperandeo MP, Argusti A, Pomponi MG, Lecora M, Sebastio GF, Perroni L, Andria G, Neri G, Bricarelli FD. Grasso M, et al. Among authors: argusti a. Am J Med Genet. 1999 Jul 30;85(3):311-6. doi: 10.1002/(sici)1096-8628(19990730)85:3<311::aid-ajmg24>3.0.co;2-a. Am J Med Genet. 1999. PMID: 10398249
Fenretinide and risk reduction of second breast cancer.
Decensi A, Zanardi S, Argusti A, Bonanni B, Costa A, Veronesi U. Decensi A, et al. Among authors: argusti a. Nat Clin Pract Oncol. 2007 Feb;4(2):64-5. doi: 10.1038/ncponc0735. Nat Clin Pract Oncol. 2007. PMID: 17259924 Clinical Trial. No abstract available.
SERMs in chemoprevention of breast cancer.
Gasco M, Argusti A, Bonanni B, Decensi A. Gasco M, et al. Among authors: argusti a. Eur J Cancer. 2005 Sep;41(13):1980-9. doi: 10.1016/j.ejca.2005.04.017. Eur J Cancer. 2005. PMID: 15964182 Review.
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: argusti a. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Puntoni M, Branchi D, Argusti A, Zanardi S, Crosta C, Meroni E, Munizzi F, Michetti P, Coccia G, De Roberto G, Bandelloni R, Turbino L, Minetti E, Mori M, Salvi S, Boccardo S, Gatteschi B, Benelli R, Sonzogni A, DeCensi A. Puntoni M, et al. Among authors: argusti a. Cancer Prev Res (Phila). 2013 Feb;6(2):74-81. doi: 10.1158/1940-6207.CAPR-12-0249. Epub 2012 Dec 4. Cancer Prev Res (Phila). 2013. PMID: 23213070 Clinical Trial.
20 results